TENET HEALTHCARE ($THC) posted quarterly earnings results on Tuesday, July 22nd. The company reported earnings of $4.02 per share, beating estimates of $2.90 by $1.12. The company also reported revenue of $5,271,000,000, beating estimates of $5,212,348,763 by $58,651,237.
You can see Quiver Quantitative's $THC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TENET HEALTHCARE Insider Trading Activity
TENET HEALTHCARE insiders have traded $THC stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $THC stock by insiders over the last 6 months:
- JAMES L BIERMAN has made 0 purchases and 4 sales selling 20,000 shares for an estimated $3,249,258.
- PAOLA M ARBOUR (EVP, Chief Information Officer) has made 0 purchases and 2 sales selling 14,199 shares for an estimated $2,373,726.
- J ROBERT KERREY has made 0 purchases and 9 sales selling 15,748 shares for an estimated $2,138,986.
- THOMAS W ARNST (EVP, Chief Admin. Officer & GC) sold 9,786 shares for an estimated $1,624,476
- RICHARD W FISHER has made 0 purchases and 2 sales selling 3,913 shares for an estimated $654,682.
- CECIL D HANEY sold 2,500 shares for an estimated $310,650
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
TENET HEALTHCARE Hedge Fund Activity
We have seen 287 institutional investors add shares of TENET HEALTHCARE stock to their portfolio, and 299 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PACER ADVISORS, INC. removed 3,832,530 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $515,475,285
- CITADEL ADVISORS LLC added 1,615,412 shares (+643.2%) to their portfolio in Q1 2025, for an estimated $217,272,914
- AMERIPRISE FINANCIAL INC added 1,524,642 shares (+348.4%) to their portfolio in Q1 2025, for an estimated $205,064,349
- FMR LLC added 1,295,346 shares (+17.9%) to their portfolio in Q1 2025, for an estimated $174,224,037
- QUBE RESEARCH & TECHNOLOGIES LTD removed 1,165,529 shares (-82.7%) from their portfolio in Q1 2025, for an estimated $156,763,650
- BLACKROCK, INC. removed 1,056,210 shares (-10.0%) from their portfolio in Q1 2025, for an estimated $142,060,245
- BOSTON PARTNERS added 1,016,010 shares (+692.9%) to their portfolio in Q1 2025, for an estimated $136,653,345
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
TENET HEALTHCARE Government Contracts
We have seen $36,120 of award payments to $THC over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- INSTRUMENT STERILIZATION: $36,120
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
TENET HEALTHCARE Analyst Ratings
Wall Street analysts have issued reports on $THC in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 07/16/2025
- Mizuho issued a "Outperform" rating on 07/11/2025
- Morgan Stanley issued a "Overweight" rating on 06/09/2025
- Barclays issued a "Overweight" rating on 06/02/2025
- Wells Fargo issued a "Overweight" rating on 05/29/2025
- B of A Securities issued a "Buy" rating on 05/14/2025
- UBS issued a "Buy" rating on 04/30/2025
To track analyst ratings and price targets for TENET HEALTHCARE, check out Quiver Quantitative's $THC forecast page.
TENET HEALTHCARE Price Targets
Multiple analysts have issued price targets for $THC recently. We have seen 12 analysts offer price targets for $THC in the last 6 months, with a median target of $191.5.
Here are some recent targets:
- David Macdonald from Truist Securities set a target price of $205.0 on 07/16/2025
- Ann Hynes from Mizuho set a target price of $194.0 on 07/11/2025
- Craig Hettenbach from Morgan Stanley set a target price of $210.0 on 06/09/2025
- Andrew Mok from Barclays set a target price of $215.0 on 06/02/2025
- Stephen Baxter from Wells Fargo set a target price of $195.0 on 05/29/2025
- Kevin Fischbeck from B of A Securities set a target price of $180.0 on 05/14/2025
- Jamie Perse from Goldman Sachs set a target price of $154.0 on 05/05/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
